Evolve BioSystems is dedicated to developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome.
Building on a decade of expertise in the partnership between the infant gut microbiome and human breast milk, Evolve is solving newborn gut dysbiosis, or an imbalance of beneficial bacteria, through microbiome-based interventions in both human and animal health.
Evivo with MCT Oil, the first and only probiotic clinically proven to work with breast milk to restore a baby's gut microbiome to its natural state, is now available as single use administration for infants in a hospital setting.
Evolve BioSystems, Inc. today announced positive results from their landmark clinical trial in support of Evivo™, an activated form of the beneficial bacteria Bifidobacterium longum subsp. infantis (B. infantis EVC001, ActiBif®).
Evolve BioSystems is pleased to announce that our Director of Immunology & Diagnostics, Dr. Bethany Henrick, will be speaking at the 3rd Annual European Microbiome Congress on November 28th in London.
Evolve BioSystems is proud to participate in the American Association of Equine Practitioners national meeting, taking place November 17-21, 2017 in San Antonio! Visit us at Booth #2078, and hear Dr. Steve Frese present the latest on GlycoGuard, the first clinically proven probiotic for nursing foals.
Dr. David Kyle, Chairman and Chief Science Officer of Evolve BioSystems, will be speaking at the Microbiome Human Nutrition Summit in Boston, November 15-16th 2017.
Evivo, recently launched in the United States, is a once daily probiotic powder given to breastfeeding infants and is clinically proven to restore the infant gut microbiome to its natural state.
On Oct. 30, 2017, Dr. Steve Frese, Evolve's Associate Director of Research and Development, will be speaking on the topic of the newborn foal microbiome at the Animal Microbiome Congress in London.
Evolve BioSystems is proud to participate in the National Association of Neonatal Nurses annual conference in Providence, Rhode Island, October 11-14th! Come visit us at Booth #326!
On Oct. 2nd, Dr. David Kyle, Chairman and Chief Science Officer of Evolve BioSystems, will be the keynote speaker, presenting: From Dysbiosis to Recovery in the Infant Gut Microbiome: A new Paradigm in Infant Nutrition.
Vienna, Austria (Sept. 22, 2017): Dr. David Kyle, Chairman and Chief Science Officer of Evolve BioSystems, will present: Rescuing the Infant Gut Microbiome.